Introduction
The mature form of transforming growth factor a (TGFa) contains 50 amino acids (Marquardt et al., 1984; Marquardt and Todaro, 1982) . It is released from the cell following cleavage from a 160 amino acid transmembrane precursor (Derynck et al., 1988; Gentry et al., 1987; Lee et al., 1985; Mueller et al., 1989) . This precursor is glycosylated and palmitoylated and has biological activity (Bringman et al., 1987; Massague, 1990) . It is preceded by an amino terminal region which contains N-and O-linked glycosylation sites which are responsible for the size heterogeneity of the TGFa precursor (Linsley et al., 1985; Luetteke et al., 1988; Teixido and Massague, 1988) . The ®rst 100 amino acids of the precursor constitute an extracellular region that contains, in the following order, an amino terminal hydrophobic signal peptide of 23 amino acids, an N-glycosylation region spanning 17 amino acids, a 50-amino-acid mature TGFa peptide, and a short juxtamembrane region. The precursor also contains a hydrophobic transmembrane domain of 25 amino acids followed by a 29-amino acid cytoplasmic domain with no known function (Derynck et al., 1984) .
The primary TGFa translation product undergoes signal sequence cleavage and glycosylation in the endoplasmic reticulum, followed by maturation of sugar chains in the Golgi compartment and transport to the plasma membrane. This membrane-bound TGFa precursor then undergoes two steps of cleavage in normal cells. Proteolytic cleavage occurs ®rst at the Nterminus of the TGFa precursor leading to loss of the N-terminal glycosylated region. This ®rst cleavage generates a 17-kDa species (by SDS electrophoretic mobility) which still contains the mature TGFa sequence. The second cleavage which occurs at the Cterminus of the mature TGFa releases the 50-amino acid mature factor (Bosenberg et al., 1992; Massague and Pandiella, 1993; Pandiella and Massague, 1991a,b) . This cleavage step generates a 15-kDa (by SDS electrophoretic mobility) pro-TGFa tail that remains in the cell membrane after release of the mature TGFa. Moreover, this cleavage occurs more slowly and appears to be regulated by several agents including protein kinase C (PKC), serum factors, and calcium ions in normal cells (Bosenberg et al., 1992; Massague and Pandiella, 1993; Pandiella and Massague, 1991a,b) .
A recent study suggests that processing of pro-TGFa may be disrupted in at least some cancer cells (Baselga et al., 1996) as pulse-chase experiments indicated that several cancer cell lines retain large amounts of the 17-kDa membrane-bound pro-TGFa species containing the 50 amino acid mature TGFa sequence after the ®rst proteolytic cleavage described above. There are relatively small amounts of the 15-kDa membrane-bound pro-TGFa tail in these cell lines. This is in contrast to normal cells in which release of the 50 amino acid mature TGFa species and conversion of the 17-kDa species to the 15-kDa pro-TGFa tail is virtually quantitative within 4 h of chase following an 35 S pulse (Arribas et al., 1996; Baselga et al., 1996) . The retention of a 17-kDa membrane-bound form of TGFa raises the possibility that this species could have dierent autocrine and/or juxtacrine eects from those of the soluble mature form of TGFa. Previous work demonstrated that juxtacrine activity could be obtained from mutant TGFa species in which the proteolytic processing sites were removed to arti®cially produce the membrane-bound form of TGFa (Brachmann et al., 1989; Wong et al., 1989) . However, the membrane form generated by this approach was found to be considerably less potent than the soluble form of TGFa. More recently, Baselga et al. (1996) showed that natively produced membrane-bound pro-TGFa from A431 cells could also activate EGFR in adjacent A431 cells in an autocrine/juxtacrine manner. Thus, it is relevant and timely to ask whether the native pro-TGFa 17-kDa form acts dierently than the soluble mature form of TGFa in its eects on EGFR activation. The question is all the more relevant since the available evidence indicates that normal cells are more ecient than cancer cells in processing TGFa to the mature 50 amino acid polypeptide (Baselga et al., 1996) .
The autocrine hypothesis was conceived to explain the growth advantage that malignant cells exhibit over normal cells (Sporn and Todaro, 1980) . The discovery that normal cells depend upon autocrine TGFa (Bates et al., 1990) raises the question as to how autocrine TGFa could dier in malignant cells in a way that provides them with a growth advantage. It has been suggested that the tethering of the 17-kDa form to the membrane could result in a more prolonged and/or sustained activation of the EGFR as well as receptor mediated downstream signaling than the eects obtained from soluble forms of TGFa (Baselga et al., 1996) . On the other hand, others have demonstrated that mutant tethered TGFa was less active than soluble TGFa (Brachmann et al., 1989) and that a mutant arti®cially tethered form of another member of the EGF family (HB-EGF) was similarly less eective than its soluble form (Miyoshi et al., 1997) .
We have compared the eects of native 17-kDa proTGFa with soluble TGFa on the activation and downstream signaling of the EGFR using two malignant cell lines which show dierent degrees of defective TGFa processing. HCT116a2aS3 cells showed a higher level of defective cleavage than CBS4aS2 cells. We demonstrate that the membrane-tethered form of TGFa induced higher levels of EGFR activation than equivalent levels of mature TGFa. The internalization of activated EGFR with membrane bound TGFa precursor was reduced relative to the internalization of soluble TGFa/EGFR complex. The inhibition of PTP activity by tethered TGFa precursor also contributed to higher EGFR activation. Moreover, the tethered form stimulated higher levels of downstream mediator activation than equivalent amounts of mature TGFa. These results suggested the potential for inappropriate EGFR activation by malignant cells relative to normal cells which quantitatively convert TGFa to the mature form.
Results

TGFa processing
Since TGFa levels in the CBS4 and HCT116a2 cells are not high enough to be detected by pulse chase/ immunoprecipitation, both of cells was transfected with a full-length wild-type TGFa cDNA in a tetracycline repressible expression vector (Sun et al., 1994) . Initially, we examined the steady state expression levels of the TGFa precursor in CBS4 parental cells and CBS4 TGFa transfectants. The TGFa precursor was detected by immunoprecipitation using a rabbit antiserum which was directed toward an epitope (amino acids 137 ± 159) present within the carboxy-terminal region of the TGFa precursor. TGFa was not detectable in CBS4 parental cells (designated as CBS4SF). However, two intermediate forms of 17-and 15-kDa were observed in CBS4aS2 and aS6 cells (Figure 1a ). Peptide competition displaced these two TGFa-immunoreactive bands indicating the speci®city of the antiserum. Since the expression vector containing TGFa cDNA is under tetracycline negative control, the addition of tetracycline in culture medium should repress TGFa expression. As expected, the CBS4aS2 cells expressed much lower levels of these two TGFa species when cultured in the presence of tetracycline (0.1 mg/ml) ( Figure 1b) . The 17-kDa form contained the mature TGFa whereas the 15-kDa band represented the transmembrane/cytoplasmic portion of the precursor that remained attached to the membrane after release of the mature TGFa (Massague and Pandiella, 1993; Pandiella and Massague, 1991b) . The intensity of the 15-kDa band relative to that of the 17-kDa form indicated that mature TGFa was readily released in CBS4aS cells. However, in contrast to normal cells, CBS4aS cells still retained signi®cant amounts of the 17-kDa pro-TGFa form.
Pulse-chase experiments were used to characterize the processing of the TGFa precursor in CBS4aS2 cells. The cells were pulse-labeled with 35 S-cysteine for 30 min and then chased with cold complete cysteine-containing medium without any growth factors for the indicated times. Several molecular weight forms were observed at time 0 corresponding to the various known TGFa intermediates (Figure 1c) . The 19 ± 22-kDa species are the primary TGFa translation products. Their molecular weight heterogeneity is due to the size of the sugar chain associated with the protein (Brachmann et al., 1989; Jiang et al., 1998b) . The appearance of the diuse 30-kDa form is most likely due to hyperglycosylation of the TGFa precursor as it proceeds through the endoplasmic reticulum and Golgi apparatus (Massague and Pandiella, 1993; Sorkin and Waters, 1993) . The 19-and 22-kDa species were then chased into the 30-kDa form which diminished over time and was followed by a gradually increasing 17-kDa band. After 30 min, a 15-kDa band appeared as the intensity of the 17-kDa form decreased, indicating that the membrane-associated form of TGFa is converted to soluble TGFa and the membrane-anchored 15-kDa transmembrane/cytoplasmic portion. The appearance of the 15-kDa intermediate is an indication that mature TGFa has been released (Massague and Pandiella, 1993) . Like the steady-state data described above, these results indicate that the TGFa precursor in CBS4aS cells is cleaved to release mature TGFa by 30 min after cold chase of pulse labeled cells with complete medium containing no growth factors. However, signi®cant amounts of the 17-kDa form were still present (*50%) after 4 h chase. This is contrast to TGFa transfected normal cells in which release of the mature TGFa and conversion of the 17-kDa species to the 15-kDa pro- (Baselga et al., 1996; Derynck et al., 1988) . The relatively large amount of 17-kDa form remaining after a 4-h chase indicated defective cleavage of membrane bound TGFa in CBS4aS cells.
TGFa processing in HCT116a2aS3 cells was characterized for comparison with CBS4aS cells. Steadystate data showed strong expression of the 17-kDa form and a weak 15-kDa band, indicating that the cells could not completely process and release mature TGFa over a 12-h period (Figure 2 ). This resulted in the retention of the processing intermediates containing mature TGFa on the cell surface of HCT116aaS cells and suggested that these cells were more defective in their processing of TGFa than the CBS4aS cells.
Modulation of TGFa processing
Previous studies have shown that serum factors, PKC modulators, and calcium transport modifying reagents could aect the processing of TGFa in normal cells (Bosenberg et al., 1992; Massague and Pandiella, 1993; Pandiella and Massague, 1991a,b) . Fetal bovine serum (FBS) enhanced TGFa processing in CBS4aS2 cells (Figure 3a) . The 15-kDa species appeared much earlier relative to untreated cells in the presence of serum. The 15-kDa species became the dominant form within 30 min post chase in the presence of 10% FBS (FBS in Figure  3a ), while it took about 60 min in the absence of serum or growth factors (SM in Figure 3a) . These indicate that release of mature TGFa is stimulated by crude serum S-cysteine for 12 h. The TGFa intermediates were immunoprecipitated from cell lysates with an antiserum against the C-terminus of the TGFa precursor and the precipitates were resolved on SDS ± PAGE and analysed by autoradiography. Some samples were preincubated with a synthetic blocking peptide (+PEP) prior to immunoprecipitation. Prestained molecular weight markers are indicated on the left and the molecular weights of the TGFa species are shown on the right. CBS4 parental cells were designated as CBS4SF. CBS4 TGFa transfectants were designated CBS4aS2 and aS6. (b) The presence of tetracycline repressed the expression of TGFa. Cells were cultured in the presence (+) or absence (7) of 0.1 mg/ml of tetracycline (TET). Metabolic labeling and processing of cell lysates were performed as described in (a). (c) Pulse-chase analysis of TGFa precursor. Cells were pulse-labeled with 35 S-cysteine for 30 min and then incubated with supplemented McCoy's 5A medium without any growth factors (SM) for dierent time periods. The TGFa precursor intermediates were immunoprecipitated as described in Materials and methods
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Enhanced activation by membrane bound TGFa H Yang et al factors. TPA, a potent enhancer of PKC activity, also stimulated TGFa processing in CBS4aS2 cells ( Figure  3b ). The 15-kDa band became the dominant species within 15 min in the presence of TPA, suggesting a role for PKC in regulating TGFa processing in these cells.
In contrast to CBS4aS2 cells, serum did not stimulate the TGFa processing in HCT116a2aS3 cells within 1 h post chase. These results indicate that HCT116a2aS3 cells have additional or dierent defects from CBS4aS2 cells. However, similarly to CBS4aS2 cells, TPA did accelerate TGFa processing in HCT116a2aS3 cells (Figure 3c ), suggesting that PKC may be involved in the regulation of TGFa processing in both of these malignant cell lines.
Membrane-bound TGFa precursors are active
TGFa exerts its stimulatory eects via interaction with the EGFR. Therefore we asked whether the membrane-bound TGFa precursor had dierent eects on EGFR activation from those of soluble mature TGFa. Co-culture of serum-starved A431 cells with either conditioned-media or re-suspended pellets of CBS4aS2 and HCT116a2aS3 cells was used to determine whether the cell surface processing intermediates containing TGFa could induce EGFR phosphorylation in A431 cells. Activation of EGFR was determined using a speci®c anti-EGFR monoclonal antibody (Transduction Laboratories) which reacts only with the tyrosine phosphorylated (activated) EGFR (Jiang et al., 1998b) . The levels of EGFR activation were stimulated by both conditioned-media and re-suspended cell pellets of both cell lines in a concentration-dependent manner (Figure 4a, b) . The activation of EGFR on the surface of A431 cells was enhanced as increasing amounts of mature TGFa from conditioned media or TGFa precursor from re-suspended cell pellets were used to treat A431 cells. Comparison of EGFR activation by tethered and soluble TGFa indicated that re-suspended cell pellets from both cell lines were more eective for EGFR activation than conditioned media at the equivalent amount of TGFa (Figure 4c,d ). Activation of EGFR was more sensitive to tethered TGFa than mature TGFa at low levels of the ligands (0.1 ng/ml). Moreover, maximal stimulation of EGFR was higher in response to tethered TGFa than soluble TGFa. Serumstarved A431 cells were also treated with human TGFa purchased from R&D systems. The EGFR activation pattern was virtually identical to that of conditioned media. This result showed that the method for quantifying mature TGFa in conditioned media or pro-TGFa precursor in re-suspended cell pellets was accurate. Nonetheless, the constraint of the tethered form to a membrane localization is likely to result in a higher local concentration of tethered TGFa presented to the A431 membrane than the soluble TGFa which is free to diuse throughout the volume of the reaction mixture. Therefore, tethering could result in a mechanism leading to enhanced TGFa concentration as a means for imparting more ecient EGFR activation.
The kinetics of EGFR activation by tethered and soluble TGFa was compared. IGF-IR protein was used as a control to normalize loading. The basal levels of activated EGFR in both CBS4aS2 and HCT116a2aS3 re-suspended cell pellets were barely detectable. This level of background EGFR activation did not alter the background level of EGFR activation of A431 cells alone which was also quite low ( Figure 5a ,b: compare the ®rst lane on the left with the second lane in each ®gure). Serum-starved A431 cells were treated with conditioned media or cell pellets for dierent time periods from 0 ± 60 min respectively. Re-suspended pellets from CBS4aS2 cells stimulated higher levels of activation of the EGFR within 5 min, relative to conditioned-media ( Figure 5a ). Moreover, peak levels of EGFR activation stimulated by the tethered TGFa were higher than those obtained with mature TGFa. Similarly, HCT116a2aS3 re-suspended pellets were more eective in stimulating activated EGFR than an equivalent amount of TGFa from conditioned-media ( Figure 5b ). These results indicate that the membraneassociated TGFa species is more eective for induction of EGFR phosphorylation than the mature form.
TGFa neutralizing antibody abrogates the EGFR activation stimulated by tethered TGFa
In order to con®rm that the EGFR activation observed was due to the tethered TGFa precursor, neutralizing antibody to TGFa was used. EGFR activation in quiescent A431 cells was low. However, when serumstarved A431 cells were treated with resuspended cell pellets from CBS4aS2 and HCT116a2aS3 cells in the absence of TGFa neutralizing antibody, the phosphorylation of EGFR on A431 cells was dramatically increased. In contrast, the activation of EGFR in A431 cells was completely suppressed in the presence of 30 mg/ml TGFa neutralizing antibody ( Figure 6 ). These data demonstrated that tethered TGFa precursors was responsible for the activation of EGFR on the cell surface of A431 cells. Scysteine overnight. The TGFa intermediates were immunoprecipitated from cell lysates with an antiserum against the C-terminus of the TGFa precursor and the precipitates were resolved on SDS ± PAGE and analysed by autoradiography. Some samples were preincubated with synthetic blocking peptide (+PEP) prior to immunoprecipitation Enhanced activation by membrane bound TGFa H Yang et al
Membrane-bound TGFa precursors delay the internalization of activated EGFR
Upon binding to receptor, growth factors are internalized via well-established receptor-mediated endocytosis processes (Sorkin and Waters, 1993) . Previous studies have shown that EGFR in high density A431 cell cultures can recycle to the plasma membrane after internalization of the receptor-ligand complex and deposition of ligand inside the cell for degradation (Masui et al., 1993) . In order to compare soluble TGFa and tethered TGFa induced internalization of EGFR from the cell surface of A431 cells, serum starved A431 cells were treated with the same amount of soluble TGFa from conditioned media and membrane bound TGFa from resuspended cell pellets for dierent time periods. Cell surface proteins of A431 cells were then biotinylated prior to immunoprecipitation of EGFR. The intracellular compartment of EGFR from A431 cells was isolated by removal of the biotinylated surface receptor from the EGFR immunocomplexes by using immobilized streptavidin. Western blot analysis of the internalized EGFR compartment with anti-activated EGFR antibody revealed that mature TGFa and tethered TGFa led to internalization of activated EGFR of A431 cells. The intracellular EGFR activation levels of A431 cells reached a maximum after 20 min and decreased by 60 min when serum starved A431 cells were treated by conditioned media of CBS4aS2 cells containing soluble TGFa (Figure 7a ). In contrast, the activation of intracellular EGFR stimulated by the tethered TGFa reached a maximum after 60 min (Figure 7c ), indicating that the rate of internalization of pro-TGFa/EGFR complex was S-cysteine for 30 min and then incubated with either supplemented McCoy's 5A medium without any growth factors (SM) or SM plus 10% fetal bovine serum (FBS) for dierent time periods (in minutes). The TGFa precursor intermediates were immuno-precipitated and analysed as described in Materials and methods. (b) The eects of TPA on the processing of TGFa precursor in CBS4aS2 cells. Cells were pulse-labeled and then incubated with SM plus TPA for dierent time periods. The TGFa precursor intermediates were immunoprecipitated and analysed as described in Materials and methods. (c) Regulation of the processing of TGFa precursor in HCT116a2aS3 cells. Cells were pulse-labeled and then incubated with either TPA, or FBS for 60 min. The TGFa precursor intermediates were immunoprecipitated and analsyed as described in Materials and methods delayed. A431 cells show an atypical behavior related to their high expression of EGFR in that the EGFRs on the cell surface are recycled after internalization (Masui et al., 1993; Sunada et al., 1990) . Thus, ligands such as TGFa only aect the activation of EGFR, not the total EGFR levels. Our data show that total intracellular EGFR levels were unchanged by reblotting with anti-EGFR antibody. Similarly, HCT116a2aS3 re-suspended pellets also resulted in the delay of internalization of the activated EGFR in A431 cells relative to soluble mature TGFa/EGFR complex (Figure 7d ). These results indicated that tethered TGFa could result in a slower internalization of pro-TGFa/EGFR complex, thus generating a more prolonged stimulatory eect on the EGFR.
Tethered TGFa precursor results in the resistance to PTP activity
High EGFR activation might be curtailed by proteintyrosine phosphate (PTPs) activity (Fischer et al., 1991; Pot and Dixon, 1992) unless activation by tethered TGFa was more resistant to PTPs action than activation mediated by soluble TGFa. Thus, we determined whether activation of EGFR by tethered TGFa was more resistant to PTP activity than EGFR activated by soluble TGFa, thus contributing to higher EGFR activation. Serum starved A431 cells were preincubated in the presence or the absence of the PTP inhibitor PAO for 30 min, and then treated with the same amount of soluble TGFa from conditioned media and membrane bound TGFa from resuspended cell pellets. The activation of EGFR on A431 cells stimulated by soluble TGFa from CBS4aS2 was dramatically increased in the presence of PAO, giving rise to a fourfold increase in EGFR phosphorylation. However, there was little dierence of EGFR activation induced by tethered TGFa with and without PAO (Figure 8a,c) . Similarly, HCT116a2aS3 re-suspended pellets were also resistant to the ability of PTP to reduce the activation of EGFR in A431 cells, relative to soluble mature TGFa (Figure 8b,d ). This result indicated that inhibition of dephosphorylation of activated EGFR by tethered TGFa contributed to higher EGFR activation.
Membrane-bound TGFa precursors activate the downstream mediators of EGFR signal transduction
The activation of EGFR leads to Ras activation. Grb2 and SHC are two critical signaling molecules connecting EGFR to Ras activation (Buday and Downward, 1993; Rozakis-Adcock et al., 1993) . The EGFR can couple to the Ras signaling pathway either directly by forming EGFR-Grb2-Sos complexes, or by utilizing the adaptor protein SHC to form EGFR-SHC-Grb2- Figure 4 Concentration dependence of contact-activated phosphorylation of EGFR. Conditioned media (24 h) were collected from 80% con¯uent CBS4aS2 and HCT116a2aS3 cell cultures and clari®ed by centrifugation. The cells were dislodged with Joklik's EDTA (GIBCO BRL) at 378C for 10 min followed by scraping. Cells were then washed with PBS twice and resuspended in 1 ml of PBS. TGFa levels in the conditioned media and the suspended cell pellets were determined as described in Materials and methods. Dierent amounts (0.1, 1, 10 and 50 ng) of mature TGFa in conditioned media and TGFa precursor in resuspended cell pellets from either CBS4aS2 cells (a) or HCT116a2aS3 cells (b) as well as human recombinant TGFa (purchased from R&D systems) were used to treat serum-starved A431 cells at 378C for 10 min. A431 cells were harvested and lysed as described in Materials and methods. Proteins were resolved by SDS ± PAGE gel, transferred to nitrocellulose and detected with activated EGFR monoclonal antibody. (c,d) AlphaImager TM (San Leandro, CA, USA) analysis was used to determine the integrated density of each band
Enhanced activation by membrane bound TGFa H Yang et al Sos complexes, or by both mechanisms together (Buday and Downward, 1993; Rozakis-Adcock et al., 1993) . Thus, we characterized Grb2 and SHC complex formation to determine whether there was dierential downstream activation of these components by soluble and tethered TGFa. Serum-starved A431 cells were treated with conditioned media or re-suspended pellets from CBS4aS2 and HCT116a2aS3 cells as described above. The higher level of activated EGFR in A431 cells stimulated by resuspended cell pellets should be re¯ected by higher levels of complex formation with SHC and Grb2. The re-suspended cell pellets, serum-starved A431 cells, and treated A431 cells were immunoprecipitated with antiactivated EGFR antibody. Resulting immunocomplexes were resolved by SDS ± PAGE and immunoblotted with SHC antibody (Figure 9a,b) . As shown above, the level of activated EGFR in re-suspended cell pellets alone was not detectable and consequently there was no detectable SHC complex formation either. In addition, the levels of the interaction of activated EGFR with SHC proteins in quiescent A431 cells and at time 0 in TGFa treated serum-starved A431 cells were relatively low. However, tethered TGFa from resuspended cell pellets of CBS4aS2 cells stimulated higher levels of association of activated EGFR with SHC protein isoforms than soluble TGFa from conditioned media (Figure 9a ), thus con®rming the higher activation of EGFR by tethered TGFa. Similarly, HCT116a2aS3 resuspended cell pellets were also more eective in coupling SHC to activated EGFR (Figure 9b ). Immunoprecipitates with antiactivated EGFR antibody from serum-starved A431 cells and treated A431 cells as well as resuspended cell pellets were followed by immunoblotting with antiGrb2 antibody. (Figure 9c,d ). Tethered TGFa from CBS4aS2 and HCT116a2aS3 was again more eective than mature TGFa in promoting the association of Grb2 with the EGFR. Furthermore, immunoprecipitates with anti-SHC antibody were analysed for associated Grb2. The association of Grb2 and SHC in re-suspended cell pellets was not detectable. Grb2/ SHC association was also low in quiescent A431 cells and at time 0 in treated A431 cells. A431 cells stimulated by tethered TGFa from CBS4aS2 cells showed higher levels of Grb2 binding to SHC than A431 cells stimulated with equivalent amounts of TGFa from conditioned media (Figure 9e) . Similarly, the tethered TGFa from HCT116a2aS3 resuspended cell pellets also stimulated the association of SHC with Grb2 more eectively than soluble TGFa (Figure 9f ).
Tethered TGFa precursors induce higher activation of MAPK signaling
The mitogen-activated protein (MAP) kinases are a family of highly conserved serine/threonine kinases activated by various extracellular signals. In order to determine whether mature TGFa and tethered TGFa precursors have dierent eects on MAP kinase activity, serum-starved A431 cells were treated with conditioned media or re-suspended pellets from CBS4aS2 and HCT116a2aS3 cells respectively. Cell lysates of A431 cells were analysed by Western blots using an antibody speci®c for the phosphorylated Prior to lysis, cell surface proteins of A431 cells were biotinylated for 60 min at room temperature. EGFR was immunoprecipitated with anti-EGFR antibody. After release from the beads, biotinylated surface EGFR of A431 cells was removed by using immobilized streptavidin. The supernatants containing the intracellular EGFR were recovered, subjected to SDS ± PAGE, and analysed by Western blotting with anti-activated EGFR antibody. The membrane was reblotted with anti-EGFR antibody (total EGFR) for normalization
Enhanced activation by membrane bound TGFa H Yang et al forms of p44 (Erk1) and p42 (Erk2) MAP kinase. The level of activated Erks in re-suspended cell pellets alone was not detectable. The phosphorylation of Erk in quiescent A431 cells and at time 0 in TGFa treated serum-starved A431 cells were relatively low. However, tethered TGFa from re-suspended cell pellets of CBS4aS2 cells induced higher activation of Erk1 and Erk2 relative to soluble TGFa from conditioned media (Figure 10a) . Similarly, HCT116a2aS3 resuspended cell pellets were also more eective in stimulating the phosphorylation of Erk (Figure 10b ). Immunoblotting with an antibody which recognizes both Erk1 and Erk2, revealed that mature TGFa and tethered TGFa had no eect on the expression of Erk1 and Erk2 protein levels. Taken together, the results indicate that pro-TGFa precursors have more pronounced eects than mature TGFa on EGFR activation and complex formation by signal transduction components in juxtacrine stimulated cells, thus, resulting in the greater activation of downstream molecules.
Discussion
This study described the defective processing of the TGFa precursor in human colon carcinoma cells. The tethered cell surface TGFa precursor stimulated the activation of EGFR on the cell surface of A431 target cells better than equivalent amounts of mature TGFa. The interaction of membrane bound TGFa precursor with the EGFR slowed the internalization of ligand-receptor complex, resulting in a more prolonged stimulatory eect on the EGFR. The activation of EGFR by tethered TGFa precursors was more resistant to protein tyrosine phosphatase activity than EGFR activated by soluble TGFa, thus contributing to more sustained EGFR activation. In addition, the 17-kDa cell surface tethered form had more pronounced eects on the generation of interactions of activated EGFR with downstream molecules and signaling. CBS4aS2 cells appear to process TGFa less eciently than normal cells which convert virtually all of their 17 kd TGFa to the mature form within 4 h of a chase following a 35 Spulse labeling period. CBS4aS2 cells showed full processing of the TGFa precursor to the mature form, but approximately half of the precursor containing mature TGFa was retained at the cell surface. In contrast, we found that there appears to be a more defective cleavage phenotype of the TGFa precursor in HCT116a2aS3 cells resulting in retention of large amounts of partially processed TGFa on the cell surface. The ratio of the 17-kDa band to the 15-kDa band is approximately 9 : 1. This suggests that in vivo wild type HCT116a cells might show more aberrant EGFR activation with respect to internalization and resistance to phosphatase action as described above than CBS cells if one made comparisons on a cell to cell basis. Indeed HCT116a cells are more aggressive with respect to tumorigeneity and growth factor independence than CBS cells (Howell et al., 1998a,b; Jiang et al., 1998b) . However, experiments in this study were normalized to the amount of tethered TGFa used to stimulate A431 cells. Therefore, the eects of tethered TGFa on EGFR activation and signaling from CBS and HCT116a cells appear to be similar as expected from this type of study design. In addition, the superiority of tethered TGFa from these cell lines contrasts with previous reports in which mature TGFa was found to be more potent than the tethered form (Brachmann et al., 1989) . This could be due to our use of wild type as opposed to mutated TGFa tethered forms or, more likely, due to the removal of the tethered form from the plasma membrane in the previous study. Removal from the membrane may have resulted in conformational changes and thus poorer binding to the EGFR.
Defective processing of TGFa in several malignant cell lines was also demonstrated by Baselga et al. (1996) . Most of the cell lines used in that study overexpress EGFR, thus suggesting that the pressure of a large excess of EGFR might be involved in the selection of malignant cell subpopulations associated with the defective TGFa cleavage phenotype. The cell lines used in this study express average levels of EGFR, thus indicating that EGFR overexpression does not select for a processing defective phenotype. Baselga et al. (1996) also showed that membranebound TGFa could form complexes with the EGFR and activate EGFR, but did not compare the tethered forms with soluble mature TGFa or determine downstream signaling eects. Comparison of the tethered forms with soluble TGFa is important because (1) defective cleavage appears to be associated predomi- Figure 9 The interaction of activated EGFR with SHC and Grb2. Equal amounts of TGFa treated A431 cell lysates, untreated A431 cell lysate and resuspended cell pellets from CBS4aS2 cells and HCT116a2aS3 cells were immunoprecipitated with the antiactivated EGFR antibody. The immunoprecipitates were resolved by SDS ± PAGE and detected with anti-SHC antibody (a,b) or anti-Grb2 antibody (c,d). Immunoprecipitates with anti-SHC antibody were also immunoblotted with anti-Grb2 antibody (e,f)
Enhanced activation by membrane bound TGFa H Yang et al nantly with malignant cells and (2) the tethered form may generate dierential activation of the EGFR which could supply malignant cells with a growth advantage over normal cells. Our results indicate that tethering of cell surface TGFa precursor does indeed lead to an increased EGFR activation and downstream signaling on neighboring A431 cells as re¯ected by association of SHC and Grb2 to the activated EGFR and increase activation of MAP kinase. An important potential dierence in the interaction between tethered TGFa with receptor and the soluble TGFa is that the tethered interaction remains very localized. This could result in an eectively higher localized concentration of TGFa. The tethered cell surface TGFa precursor was able to activate EGFR in adjacent A431 cells in a juxtacrine manner. Previous work demonstrated that juxtacrine activity could be obtained from mutant TGFa species in which the proteolytic processing sites were removed to arti®cially produce the membrane-bound form of TGFa (Brachmann et al., 1989; Wong et al., 1989) . In addition to higher localized concentration, it is possible that there are qualitative dierences between soluble and tethered TGFa forms. Tethered TGFa/EGFR complexes might be expected to be more resistant to internalization than soluble TGFa/EGFR complexes; especially, if the tethered TGFa was acting in a juxtacrine manner. Our data indicated that EGFR activated by the membrane-bound TGFa showed delayed internalization characteristics relative to EGFR activated by soluble TGFa. The observation that there was resistance to phosphatase by EGFR activated with tethered TGFa, but not by EGFR activated by the soluble form was unexpected. Resistance to phosphatase action may result from delayed internalization. Alternatively, we speculate that binding of tethered TGFa alters the cytoplasmic portion of the EGFR in a way that prevents its dephosphorylation or that a phosphate docking site is not phosphorylated eciently in tethered TGFa stimulation. The alterations in phosphorylation and internalization could result in defects in dephosphorylation.
Enhanced EGFR activation by tethered TGFa is pertinent to an important issue regarding autocrine TGFa activity and its role in determining malignant behavior. Several lines of evidence indicate that autocrine TGFa contributes to the malignant phenotype. These lines of evidence include (a) the development of neoplasia and hyperplasia in response to inappropriate TGFa expression in transgenic animals (Jhappan et al., 1990; Matsui et al., 1990; Sandgren et al., 1990) ; (b) higher levels of TGFa expression in malignant tumors relative to normal counterpart tissues (Matsui et al., 1990) ; and (c) malignant progression of human colon cancer xenografts following expression of TGFa (Howell et al., 1998a,b; Jhappan et al., 1990; Ziober et al., 1993) . However, it is clear that normal epithelial cells and premalignant cells from adenomas also utilize autocrine TGFa in their growth regulatory mechanisms (Bates et al., 1990; Markowitz et al., 1990) . Thus, it is of importance to de®ne how normal cell and malignant cell autocrine TGFa mechanisms dier. Enhanced activation of the EGFR resulting from the tethered form of TGFa in processing defective cells is a reasonable mechanism whereby a growth advantage may be impaired to malignant cells since it has been shown that inappropriate EGFR activation is transforming (Khazaie et al., 1993) and that naturally occurring truncated constitutively activated forms of the EGFR have been associated with some types of human tumors (Nagane et al., 1996) . 
Materials and methods
Materials
Antiserum to the C-terminus of the TGFa precursor has been previously described (Gentry et al., 1987) . TPA (12-O-tetradecanoylphorbol-13-acetate) was from Sigma (St. Louis, MO, USA). L-[ 35 S]cysteine, Enhanced Chemi-Luminescent Substrate (ECL) and ECL ®lm were from Amersham (Arlington Heights, IL, USA). Protein A-agarose was obtained from GIBCO BRL (Gaithersburg, MD, USA). TGFa neutralizing antibody was obtained from Oncogene Science (Cambridge, MA, USA). Anti-EGFR monoclonal antibody and antibody to the activated EGFR were purchased from Transduction Laboratories (Lexington, KY, USA). SHC antibody was obtained from Upstate Biotechnology (Lake Placid, NY, USA). Rabbit polyclonal Grb2 (C-23), phospho-Erk, and anti-Erk antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Cell culture
Human colon carcinoma cell lines CBS and HCT116a have been described (Brattain et al., 1984; Jiang et al., 1998a) . Typical limiting dilution clones of these two cell lines designated CBS4 and HCT116a2 were transfected with a tetracycline-repressible vector (Gossen and Bujard, 1992; Sun et al., 1994) containing a full length TGFa cDNA (Derynck et al., 1984) . CBS4 TGFa clones 2 and 6 (designated as CBS4aS2 and CBS4aS6, respectively), and HCT116a2 TGFa clone 3 (designated as HCT116a2aS3) were used in this study. These cells were maintained in a serum-free medium which consists of McCoy's 5A medium supplemented with antibiotics, nutrients (amino acids, pyruvate, vitamins) and transferrin (4 mg/ml, Sigma), insulin (20 mg/ml, Sigma), and EGF (10 ng/ml, R&D System, Minneapolis, MN, USA) (Mulder and Brattain, 1989) . A431 squamous carcinoma cells were obtained from ATCC and cultured in McCoy's 5A medium supplemented with 10% fetal bovine serum (Sigma).
Metabolic labeling
Cells were grown to 80% con¯uence in 35-mm dishes in serum free medium. The cells were washed twice with cysteine-free MEM (GIBCO BRL) and incubated with cysteine-free MEM for 30 min. The medium was then replaced with cysteine-free MEM containing 250 mCi/ml L-[ .4], 150 mM NaCl, 0.5% sodium deoxycholate, 1% Triton X-100, 1 mM EDTA and freshly added protease inhibitors including 1 mM phenyl methyl sulfonyl¯uoride, 5 mg/ml of leupeptin and 25 mg/ml each of aprotinin, trypsin inhibitor, and pepstatin A). The lysates were clari®ed by centrifugation at 10 000 g for 30 min at 48C.
Equal amounts of labeled samples (2 ± 5610 7 c.p.m. sample) were pre-cleared with a 50% protein A-agarose suspension for 30 ± 60 min at 48C. After centrifugation, the supernatants were incubated with 5 ml of rabbit antiserum against the C-terminus of the TGFa precursor overnight at 48C. This anti-serum has been previously described (Gentry et al., 1987) . Samples were subsequently incubated with a 50% protein A-agarose suspension for 30 min at 48C. Immunocomplexes were washed twice with RIPAE buer and three times with wash buer (20 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM EDTA, and 0.2% NP-40). Pellets were resuspended in sample buer (0.125 M Tris-HCl [pH 6.8], 4% SDS, 10% glycerol and 4% b-mercaptoethanol), heated for 5 min at 958C, and resolved by 12.5% SDS ± PAGE. Gels were ®xed, treated with 1 M sodium salicylate, dried and exposed to Kodak XAR-5 ®lm.
Western immunoblotting
Cell cultures were washed with cold PBS buer and harvested in cold lysis buer (0.5% NP-40, 50 mM Tris-HCl [pH 7.4], 150 mM NaCl with freshly added phosphatase and protease inhibitors including 50 mM NaF, 1 mM Na 3 VO 4 , 2 mM bglycerophosphate, 1 mM PMSF, 25 mg/ml leupeptin, 25 mg/ml aprotinin, and 25 mg/ml trypsin inhibitor). Crude cell lysates were passed through a 21 gauge needle four times to sheer chromosomal DNA, incubated on ice for 30 min, and then centrifuged for 20 min at 48C. Samples were subjected to SDS ± PAGE followed by transferring to nitrocellulose membranes. Membranes were blocked with TTBS buer (20 mM Tris-HCl [pH 7.5], 0.5 M NaCl, 0.05% Tween-20) containing 5% nonfat dried milk at 48C and incubated with the primary antibody in TTBS containing 5% nonfat milk overnight. The membranes were then incubated with a horseradish peroxidase conjugated secondary antibody for 1 ± 2 h at room temperature, washed twice with water, and once with TTBS buer for 5 min. The blots were immersed in ECL for 1 min and exposed to ECL ®lm.
Immunoprecipitation
The lysates were immunoprecipitated with antibody overnight at 48C. Immune complexes were collected with protein Aagarose and washed twice with lysis buer. Bound proteins were released by heating for 5 min at 958C in sample buer. The immunoprecipitates were resolved by SDS ± PAGE, then transferred to nitrocellulose and subjected to Western blot analysis with detection by the ECL method (Amersham).
Contact-activated phosphorylation of EGFR
Human TGFa was purchased from R&D systems (Minneapolis, MN, USA) and iodinated by the chloramine T method as described by Ru and Rizzino (1986) to a speci®c activity of 20 000 c.p.m./ml. The TGFa antibody employed in the development of this assay can recognize both mature TGFa and pro-TGFa precursors. The TGFa antibody was incubated with a mixture of recombinant 125 I-TGFa and unlabeled TGFa at 48C overnight. Protein A-agarose was added and agitated for 30 min at 48C. The agarose matrix was collected by centrifugation, then suspended in lysis buer containing 0.5% SDS, heated and counted in a LKB gamma counter. A range of unlabeled recombinant TGFa concentrations (0 ng ± 10 mg) was used to compete with I-TGFa binding to the antibody. Protein Aagarose was added, the resulting immunocomplex was released by heating and then counted in an LKB gamma counter. Sample counts were compared to the standard curve to determine the amount of TGFa.
CBS4aS2 and HCT116a2aS3 cells were cultured in serumfree medium lacking EGF. Conditioned media (24 h) were collected from 80% con¯uent cultures and clari®ed by centrifugation. The cells were dislodged by incubation with Joklik's EDTA (GIBCO BRL) at 378C for 10 min followed by scraping, washed twice with PBS and resuspended in 1 ml of PBS. The cells were counted with a hemocytometer. The conditioned media and the suspended cell pellets were ITGFa for binding to antibody. The concentration of TGFa in conditioned media or the concentration of pro-TGFa precursors in suspended cell pellets was determined by the corresponding counts from the standard TGFa curve constructed as described above. Mature TGFa and precursors generated by CBS4aS2 and HCT16a2aS3 cells were used to treat serum-starved A431 cells at 378C. The A431 cells were then harvested and cell lysates were subjected to analysis for EGFR activation and complex formation with signal transduction components. Comparison of the activation of EGFR by known amounts of recombinant TGFa and medium derived TGFa whose concentration was determined from the standard curve were essentially identical (Figure 4) , thus validating this method for TGFa quantitation.
Isolation of internalized EGFR
The isolation of internalized EGFR was performed as described by Olayioye et al. (1998) . Brie¯y, serum starved A431 cells were treated for dierent time periods with the same amount of soluble TGFa and tethered TGFa generated by CBS4aS2 and HCT16a2aS3 cells, respectively. Treated A431 cells were washed twice with PBS, dislodged by incubation with Joklik's EDTA (GIBCO BRL) at room temperature for 10 min, harvested, washed twice with PBS and resuspended in 1 ml of PBS. Prior to lysis, the surface proteins of A431 cells were biotinylated with NHS-SS-biotin (Pierce) for 60 min at room temperature, washed three times with cold PBS and then lysed in lysis buer with freshly added phosphatase and protease inhibitors as described above. Immunoprecipitation of EGFR with monoclonal EGFR antibody was performed as described above. The immunoprecipitates collected with protein A-agarose were washed twice with lysis buer and released from beads by heating for 10 min at 958C in lysis buer containing 0.5% SDS. The supernatants were collected, and biotinylated EGFR on the cell surface of A431 cells was removed by using immobilized streptavidin. The supernatants which contained the non-biotinylated intracellular fraction of EGFR were resolved by SDS ± PAGE, then transferred to nitrocellulose and subjected to Western blot analysis.
The effect of PAO on EGFR phosphorylation
Serum starved A431 cells were treated for 10 min at 378C with the same amount of soluble TGFa and tethered TGFa generated by CBS4aS2 and HCT16a2aS3 cells, respectively. Prior to stimulation, serum starved A431 cells treated with PTP inhibitor were preincubated with 40 mM PAO at 378C for 30 min as described by Sorby and Ostman (1996) . After stimulation, cells were washed twice with cold PBS and then lysed in lysis buer with freshly added phosphatase and protease inhibitors as described above. Proteins were resolved by SDS ± PAGE, transferred to nitrocellulose and detected with activated EGFR monoclonal antibody.
Abbreviations
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